Inovio Pharmaceuticals, Inc.
Vaccines with CD40 ligand as an adjuvant

Last updated:

Abstract:

Disclosed herein is a vaccine comprising an antigen and CD40L. Also disclosed herein are methods for increasing an immune response in a subject. The methods may comprise administering the vaccine to the subject in need thereof.

Status:
Grant
Type:

Utility

Filling date:

18 Mar 2016

Issue date:

23 Feb 2021